183 related articles for article (PubMed ID: 16595635)
1. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse.
Lettau M; Qian J; Linkermann A; Latreille M; Larose L; Kabelitz D; Janssen O
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5911-6. PubMed ID: 16595635
[TBL] [Abstract][Full Text] [Related]
2. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.
Baum W; Kirkin V; Fernández SB; Pick R; Lettau M; Janssen O; Zörnig M
J Biol Chem; 2005 Dec; 280(48):40012-24. PubMed ID: 16204241
[TBL] [Abstract][Full Text] [Related]
3. The molecular mechanism of FasL-mediated cytotoxicity by CD4+ Th1 clones.
el-Khatib M; Stanger BZ; Dogan H; Cui H; Ju ST
Cell Immunol; 1995 Jul; 163(2):237-44. PubMed ID: 7541726
[TBL] [Abstract][Full Text] [Related]
4. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
5. Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes.
Hallermalm K; De Geer A; Kiessling R; Levitsky V; Levitskaya J
Cancer Res; 2004 Sep; 64(18):6775-82. PubMed ID: 15374996
[TBL] [Abstract][Full Text] [Related]
6. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
9. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding.
Blossom SJ; Gilbert KM
Toxicol Sci; 2006 Jul; 92(1):103-14. PubMed ID: 16641322
[TBL] [Abstract][Full Text] [Related]
10. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD
Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292
[TBL] [Abstract][Full Text] [Related]
11. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
[TBL] [Abstract][Full Text] [Related]
13. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
[TBL] [Abstract][Full Text] [Related]
15. FasL cross-linking inhibits activation of human peripheral T cells.
Paulsen M; Mathew B; Qian J; Lettau M; Kabelitz D; Janssen O
Int Immunol; 2009 May; 21(5):587-98. PubMed ID: 19332441
[TBL] [Abstract][Full Text] [Related]
16. The adaptor protein Grb2 regulates cell surface Fas ligand in Schwann cells.
Thornhill PB; Cohn JB; Stanford WL; Desbarats J
Biochem Biophys Res Commun; 2008 Nov; 376(2):341-6. PubMed ID: 18789888
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
18. A new role of diacylglycerol kinase alpha on the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes.
Alonso R; Mazzeo C; Mérida I; Izquierdo M
Biochimie; 2007 Feb; 89(2):213-21. PubMed ID: 16989932
[TBL] [Abstract][Full Text] [Related]
19. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
Groh V; Smythe K; Dai Z; Spies T
Nat Immunol; 2006 Jul; 7(7):755-62. PubMed ID: 16732291
[TBL] [Abstract][Full Text] [Related]
20. Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia.
Li W; Fu J; Wang F; Yu G; Wang Y; Zhang X
Cell Mol Immunol; 2004 Apr; 1(2):142-7. PubMed ID: 16212902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
